1832 Asset Management L.P. Moderna, Inc. Transaction History

1832 Asset Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$101.21 - $166.61 $2,530 - $4,165	25 New	25 $2,000
Q3 2023 Nov 13, 2023	BUY	$96.41 - $126.61 $1.05 Million - $1.38 Million	10,913 New	10,913 $1.13 Million
Q2 2023 Aug 11, 2023	BUY	$118.5 - $160.53 $62,568 - $84,759	528 Added 3.38%	16,157 $1.96 Million
Q1 2023 May 12, 2023	BUY	$135.66 - $197.02 $2.12 Million - $3.08 Million	15,614 Added 104093.33%	15,629 $2.4 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $3.25 Million - $5.34 Million	-27,500 Reduced 99.95%	15 $2,000
Q2 2022 Aug 15, 2022	BUY	$117.13 - $176.59 $3.22 Million - $4.86 Million	27,500 Added 183333.33%	27,515 $3.93 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $1,896 - $3,525	15 New	15 $3,000
Q4 2021 Feb 15, 2022	SELL	$225.82 - $368.51 $547,839 - $894,005	-2,426 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $538,329 - $1.18 Million	2,426 New	2,426 $925,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.